You are a senior bioengineer working for a liquid biopsy diagnostics company. Your company can use one of two assay technologies for a painless and relatively low-cost early detection of pancreatic cancer using typical 10mL blood draw. Assay technology Alpha results in a sensitivity of 99.5% and a specificity 98%. Assay technology Beta has a sensitivity of 99.0% and a specificity of 99.8%. The incidence rate is 13.2 per 100,000 men and women per year. 18. If 1,000,000 random people receive a liquid biopsy assay with the Alpha technology, how many false-positives will result? How many true-positives? How many false-negatives? 19. If 1,000,000 random people receive a liquid biopsy assay with the Beta technology, how many false-positives will result? How many true-positives? How many false-negatives